Market cap
$137m
Earnings yield vs 10-yr compares what the business earns per pound invested against the 5.28% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
The Company ended the second quarter of 2026 with $12.0 million in net revenues, an 18.2% increase compared to $10.2 million in the same period last year. Revenues were driven by growth in our core domestic and international business of 12.4% and 59.1%, respectively, along with a decrease of 35% in our pharma services and clinical trials business. Gross profit for the second quarter of 2026 was $7.8 million, a 21.2% increase compared to $6.5 million in the same period last year. Gross margin was 65.1% for the three months ended June 30, 2026, an increase from 63.5% in the prior year period. …KORU Medical Systems, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-05